Medicis Plans To Build On Zyclara After Graceway Acquisition
This article was originally published in The Pink Sheet Daily
Medicis begins to flesh out plans for the company after the acquisition of Graceway by building the Zyclara franchise and finishing development of the pipeline products.
You may also be interested in...
The specialty pharma adds to its dermatology portfolio with a proposed acquisition of Scottsdale, Ariz.-based Medicis.
Newly approved plant-based gel works in just a few days of treatment, rather than the weeks required for some competitors.
Headed by former King chief Gregory, the nine-month-old Tennessee pharma gains access to 3M’s immune response modifier platform on which to build a portfolio.